GlassScriptPhysician profile
Dennis W Grandy
NPI 1841286861
$1,253.91
in general payments reported to CMS, 2019-2025
9 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2021: $86.34 · 2022: $112 · 2023: $76.93 · 2024: $412 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $294.05 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Paragon 28, INC. | $232.50 | 2022-2024 | Precision Mis Bunion |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $189.86 | 2019-2024 | Jublia |
| Amgen INC. | $150.00 | 2025 | Krystexxa |
| Integra Lifesciences Corporation | $135.51 | 2019 | |
| Bioventus LLC | $130.95 | 2024 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $66.73 | 2019 | |
| Organogenesis INC. | $38.49 | 2021 | |
| Horizon Therapeutics Plc | $15.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Grandy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.